Efavirenz in human breast milk, mothers', and newborns' plasma.
about
Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeedingEfavirenz in the therapy of HIV infection.Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study.AtriplaR/anti-TB combination in TB/HIV patients. Drug in focusLactation-associated postpartum weight changes among HIV-infected women in Zambia.Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies.The Expanding Class of Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV-1 InfectionNelfinavir and its active metabolite, hydroxy-t-butylamidenelfinavir (M8), are transferred in small quantities to breast milk and do not reach biologically significant concentrations in breast-feeding infants whose mothers are taking nelfinavir.Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.Pharmacotherapy of pediatric HIV infectionAntiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.Pharmacokinetic optimization of antiretroviral therapy in pregnancy.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.High Rates of Baseline Drug Resistance and Virologic Failure Among ART Naïve HIV-Infected Children in Mali.Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi.Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.
P2860
Q30679524-EE06C140-B98B-49F7-9813-75D06280F382Q33607011-CA0F1D0F-A378-48C9-8D52-728F72DDCA9DQ33946645-F441B344-8E3C-4481-8E59-CD5C3AADEBC2Q34083071-86538A87-8BEA-4FCE-9943-B8B8DDE9E249Q34274437-CED547F3-0BD6-41EE-BD3A-F7E3CFCC2137Q34470986-1A4C3398-14A8-415F-BBA7-2EB8AA2AE989Q35111300-99928812-68BB-4773-86DE-E3465A9097BFQ35364022-79AAA811-1DD7-4813-A475-33C647738654Q36113222-2E2604BD-E532-4B12-9E2D-D67E53291D46Q36301325-F2E8EAEB-4A10-496A-B016-BE920679DBCEQ37115759-C5448D48-D8D5-4A56-804D-D9A3ED784762Q38047214-A853DFAF-7C54-4659-B68F-1D554D3AA6E5Q38051400-66B96875-A671-467A-8A28-BFB526D0E122Q38960646-A1A8C2C2-711E-4060-A700-FF4521C811C2Q40867191-34D902F9-23DB-4422-A1A3-1CD374EDB5E8Q50568163-D7D3F58A-A7CB-4869-BBA3-FFEE5202CC94
P2860
Efavirenz in human breast milk, mothers', and newborns' plasma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Efavirenz in human breast milk, mothers', and newborns' plasma.
@en
Efavirenz in human breast milk, mothers', and newborns' plasma.
@nl
type
label
Efavirenz in human breast milk, mothers', and newborns' plasma.
@en
Efavirenz in human breast milk, mothers', and newborns' plasma.
@nl
prefLabel
Efavirenz in human breast milk, mothers', and newborns' plasma.
@en
Efavirenz in human breast milk, mothers', and newborns' plasma.
@nl
P2093
P1476
Efavirenz in human breast milk, mothers', and newborns' plasma.
@en
P2093
Alain Gras
Alexandra Peltier
Anastasie Mujawamariwa
Christine Karasi-Omes
Gilles Ndayisaba
Patrick C Ndimubanzi
Robert Wennig
Serge Schneider
Vic Arendt
P304
P356
10.1097/QAI.0B013E31817BBC21
P407
P577
2008-08-01T00:00:00Z